VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar pchop123 (79.60) Submitted: 1/14/2013 2:22:57 PM : Outperform Start Price: $14.03 VVUS Score: -5.96

good entry price here for this obesity drug

Featured Broker Partners


Advertisement